Thor Medical ASA (TRMED.OL) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Norway · ISIN NO0010597883
Price
4.22 NOK
Market cap
1.78 bn NOK
P/E (2025)
–
P/S (2025)
4,056.59
Dividend yield
0.00 %
Net margin
-13,214.81 %
Return on equity (ROE)
-12.72 %
Return on assets (ROA)
-8.19 %
Thor Medical ASA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 NOK | 439,000.00 NOK |
| Gross profit | -2.38 m NOK | 839,000.00 NOK |
| Operating income | -52.71 m NOK | -69.65 m NOK |
| EBIT | -43,931.00 NOK | -61.67 m NOK |
| Net income | -42.21 m NOK | -58.01 m NOK |
| Diluted EPS – continuing operations | -0.18 NOK | -0.16 NOK |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
More stocks
- Firy Inc. (FIRY)
- EASTERN CO (EML)
- Humedix Co Ltd (200670.KQ)
- TBI Motion Technology Co Ltd (4540.TW)
- Trisul S.A (TRIS3.SA)
- Sparebank 1 Nordvest (SNOR.OL)
- Petrus Resources Ltd (PRQ.TO)
- Akwel SA (AKW.PA)
- Finward Bancorp (FNWD)
- AzureWave Technologies Inc (3694.TW)
- CITIZENS, INC. (CIA)
- Muramoto Electron (Thailand) Public Company Limited (METCO.BK)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.